Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians

Respiratory Syncytial Virus (RSV) is a leading cause of morbidity and hospitalization in all infants. Many RSV vaccines and monoclonal antibodies (mAb) are currently under development to protect all infants, but to date preventive options are available only for preterms. In this study, we assessed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccò, Matteo, Corrado, Silvia, Cerviere, Milena Pia, Ranzieri, Silvia, Marchesi, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944855/
https://www.ncbi.nlm.nih.gov/pubmed/36810343
http://dx.doi.org/10.3390/pediatric15010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944855/
https://www.ncbi.nlm.nih.gov/pubmed/36810343
http://dx.doi.org/10.3390/pediatric15010013

Ejemplares similares